Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Transition Award (R00)
Project #
4R00CA148963-02
Application #
8734665
Study Section
Special Emphasis Panel (NSS)
Program Officer
Mufson, R Allan
Project Start
2013-09-20
Project End
2016-08-31
Budget Start
2013-09-20
Budget End
2014-08-31
Support Year
2
Fiscal Year
2013
Total Cost
$234,061
Indirect Cost
$78,539

  Institution

Name
University of Nebraska Medical Center
Department
Biochemistry
Type
Schools of Medicine
DUNS #
168559177
City
Omaha
State
NE
Country
United States
Zip Code
68198

  Publications

Richter, Lisa; Wang, Yiqian; Hyde, R Katherine (2016) Targeting binding partners of the CBF?-SMMHC fusion protein for the treatment of inversion 16 acute myeloid leukemia. Oncotarget 7:66255-66266
Hyde, R K; Zhao, L; Alemu, L et al. (2015) Runx1 is required for hematopoietic defects and leukemogenesis in Cbfb-MYH11 knock-in mice. Leukemia 29:1771-8
Kamikubo, Yasuhiko; Hyde, R Katherine; Zhao, Ling et al. (2013) The C-terminus of CBF?-SMMHC is required to induce embryonic hematopoietic defects and leukemogenesis. Blood 121:638-42